Literature DB >> 2303316

Thymosin alpha 1 modulates the expression of high affinity interleukin-2 receptors on normal human lymphocytes.

K D Leichtling1, S A Serrate, M B Sztein.   

Abstract

In this report we demonstrate that thymosin alpha 1 (T alpha 1), a synthetic peptide composed of 28 amino acid residues, and thymosin fraction 5 (TF5) enhance the number of high affinity interleukin 2 receptors (IL-2R) expressed by human peripheral blood lymphocytes in response to in vitro stimulation with phytohemagglutinin (PHA). Thymosins did not, however, alter the affinity of the IL-2R for its ligand. Dose-response studies using a wide range of concentrations indicated a bimodal distribution of responsiveness to T alpha 1. In most experiments the high and low concentration peaks of activity were observed at 10(-8) M and 10(-12) M, respectively, although peak responses were observed at different T alpha 1 concentrations in different donors. No effects were elicited by thymosins in the absence of mitogenic stimulation. Thymosin enhancement of PHA-induced high affinity IL-2R expression directly correlated with increased levels of Tac antigen expression, as determined by flow cytometry, and enhanced interleukin 2 (IL-2) production. Since the biological effects of IL-2 are associated with the occupancy of high affinity IL-2R, the findings presented in this report strongly suggest that thymosins play a significant role in the regulation of immune responses through the modulation of high affinity IL-2R expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2303316     DOI: 10.1016/0192-0561(90)90064-t

Source DB:  PubMed          Journal:  Int J Immunopharmacol        ISSN: 0192-0561


  11 in total

1.  Expression of alpha-thymosins in human tissues in normal and abnormal growth.

Authors:  O E Tsitsiloni; J Stiakakis; A Koutselinis; J Gogas; C Markopoulos; P Yialouris; S Bekris; D Panoussopoulos; V Kiortsis; W Voelter
Journal:  Proc Natl Acad Sci U S A       Date:  1993-10-15       Impact factor: 11.205

2.  A randomized controlled trial of thymalfasin plus transarterial chemoembolization for unresectable hepatocellular carcinoma.

Authors:  Robert G Gish; Stuart C Gordon; David Nelson; Vinod Rustgi; Israel Rios
Journal:  Hepatol Int       Date:  2009-05-08       Impact factor: 6.047

Review 3.  Roles of thymosins in cancers and other organ systems.

Authors:  Changyi Chen; Min Li; Hui Yang; Hong Chai; William Fisher; Qizhi Yao
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

4.  Circulating soluble interleukin 2 receptor concentration is increased in both immunogenic and nonimmunogenic hyperthyroidism.

Authors:  S Mariotti; P Caturegli; G Barbesino; G F Del Prete; L Chiovato; A Pinchera
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

5.  Suppression by Trypanosoma brucei rhodesiense of the capacities of human T lymphocytes to express interleukin-2 receptors and proliferate after mitogenic stimulation.

Authors:  F Kierszenbaum; S Muthukkumar; L A Beltz; M B Sztein
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C.

Authors:  J A Coto; E M Hadden; M Sauro; N Zorn; J W Hadden
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

7.  Molecular characterization, tissue distribution, subcellular localization and actin-sequestering function of a thymosin protein from silkworm.

Authors:  Wenping Zhang; Changrong Zhang; Zhengbing Lv; Dailing Fang; Dan Wang; Zuoming Nie; Wei Yu; Hanglian Lan; Caiying Jiang; Yaozhou Zhang
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

8.  Expression and hydroxylamine cleavage of thymosin alpha 1 concatemer.

Authors:  Liang Zhou; Zong-Teng Lai; Min-Kan Lu; Xing-Guo Gong; Yi Xie
Journal:  J Biomed Biotechnol       Date:  2008

9.  A tumor-penetrating peptide modification enhances the antitumor activity of thymosin alpha 1.

Authors:  Xingzhen Lao; Meng Liu; Jiao Chen; Heng Zheng
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

10.  Thymosin α1 Interacts with Hyaluronic Acid Electrostatically by Its Terminal Sequence LKEKK.

Authors:  Walter Mandaliti; Ridvan Nepravishta; Francesca Pica; Paola Sinibaldi Vallebona; Enrico Garaci; Maurizio Paci
Journal:  Molecules       Date:  2017-10-27       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.